The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator
- PMID: 1850423
The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator
Abstract
The purified urokinase plasminogen activator receptor (u-PAR) was cleaved into two fragments by mild chymotrypsin treatment. The smaller fragment (apparent Mr 16,000) possessed the ligand-binding capability, as shown by chemical cross-linking analysis. This fragment constituted the NH2-terminal part of the intact receptor, probably including the whole sequence 1-87, and contained N-linked carbohydrate. After detergent phase separation in the Triton X-114 system, the fragment was present in the water phase where its binding activity could be demonstrated in the absence of the rest of the protein. An analysis of internal homology in the amino acid sequence of u-PAR revealed the presence of three repeats of approximately 90 residues each. The ligand-binding fragment corresponds to the first repeat, supporting that this unit is a structurally autonomous domain. Domains homologous with the internal repeats of u-PAR constitute the extracellular part of Ly-6 antigens and of the squid glycoprotein Sgp-2. Like u-PAR, these proteins are attached to the membrane by a glycosyl-phosphatidylinositol anchor. The hydrophilic, ligand-binding u-PAR domain identified in the present study has potential applications in interfering with cell-surface plasmin-mediated proteolysis.
Similar articles
-
N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.J Biol Chem. 1993 May 25;268(15):11152-9. J Biol Chem. 1993. PMID: 8388383
-
Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.Thromb Haemost. 1998 Jul;80(1):148-54. Thromb Haemost. 1998. PMID: 9684801
-
Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.Eur J Biochem. 1992 Apr 15;205(2):451-8. doi: 10.1111/j.1432-1033.1992.tb16799.x. Eur J Biochem. 1992. PMID: 1374026
-
Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor.Curr Pharm Des. 2003;9(19):1499-528. doi: 10.2174/1381612033454630. Curr Pharm Des. 2003. PMID: 12871065 Review.
-
Plasminogen activation by receptor-bound urokinase.Semin Thromb Hemost. 1991 Jul;17(3):194-200. doi: 10.1055/s-2007-1002609. Semin Thromb Hemost. 1991. PMID: 1665584 Review. No abstract available.
Cited by
-
Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.Mol Biol Cell. 2001 May;12(5):1467-79. doi: 10.1091/mbc.12.5.1467. Mol Biol Cell. 2001. PMID: 11359936 Free PMC article.
-
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.J Exp Med. 1998 Sep 21;188(6):1029-37. doi: 10.1084/jem.188.6.1029. J Exp Med. 1998. PMID: 9743521 Free PMC article.
-
The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.J Biol Chem. 2008 Oct 24;283(43):29554-62. doi: 10.1074/jbc.M802579200. Epub 2008 Aug 18. J Biol Chem. 2008. PMID: 18713736 Free PMC article.
-
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.EMBO J. 1996 Apr 1;15(7):1572-82. EMBO J. 1996. PMID: 8612581 Free PMC article.
-
A hybrid protein of the amino-terminal fragment of urokinase and mutant plasminogen activator inhibitor-2 efficiently inhibits tumor cell invasion and metastasis.J Cancer Res Clin Oncol. 2005 Feb;131(2):129-36. doi: 10.1007/s00432-004-0623-2. Epub 2004 Oct 12. J Cancer Res Clin Oncol. 2005. PMID: 15490235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials